Statin Intolerance: the Clinician’s Perspective

Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

(2015) Maciej Banach et al.   Archives of Medical Science

A randomized trial of coenzyme Q10 in patients with confirmed Statin Myopathy

(2015) Beth A. Taylor et al.   ATHEROSCLEROSIS

Classification of reported statin intolerance

(2015) David Preiss et al.   CURRENT OPINION IN LIPIDOLOGY

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

Statin Intolerance

(2015) Connie B. Newman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Coenzyme Q10 on Statin-Induced Myopathy

(2015) Maciej Banach et al.   MAYO CLINIC PROCEEDINGS

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

(2015) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Intolerance: Diagnosis and Remedies

(2015) Angela Pirillo et al.   Current Cardiology Reports

Non-traditional Dosing of Statins in Statin-Intolerant Patients—Is It Worth a Try?

(2014) Marc-Andre Cornier et al.   Current Atherosclerosis Reports

Statins, Glycemia, and Diabetes Mellitus: Another Point of View

(2014) Tomáš Štulc et al.   Current Atherosclerosis Reports

An assessment by the Statin Muscle Safety Task Force: 2014 update

(2014) Robert S. Rosenson et al.   Journal of Clinical Lipidology

An assessment by the Statin Cognitive Safety Task Force: 2014 update

(2014) Carlos H. Rojas-Fernandez et al.   Journal of Clinical Lipidology

An assessment by the Statin Liver Safety Task Force: 2014 update

(2014) Harold Bays et al.   Journal of Clinical Lipidology

An assessment by the Statin Intolerance Panel: 2014 update

(2014) John R. Guyton et al.   Journal of Clinical Lipidology

Hypothyroidism as a risk factor for statin intolerance

(2014) Craig D. Robison et al.   Journal of Clinical Lipidology

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience

(2013) Warner M. Mampuya et al.   AMERICAN HEART JOURNAL

Discontinuation of Statins in Routine Care Settings

(2013) Huabing Zhang et al.   ANNALS OF INTERNAL MEDICINE

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update

(2013) G.B. John Mancini et al.   CANADIAN JOURNAL OF CARDIOLOGY

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

(2013) Melissa Y. Wei et al.   Journal of Clinical Lipidology

Effect of Statins on Skeletal Muscle Function

(2012) Beth A. Parker et al.   CIRCULATION

Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle

(2011) Charles J. Glueck et al.   MEDICAL HYPOTHESES

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

(2010) Min Jun et al.   LANCET

Efficacy of Rosuvastatin (5 mg and 10 mg) Twice a Week in Patients Intolerant to Daily Statins

(2008) Mamatha Gadarla et al.   AMERICAN JOURNAL OF CARDIOLOGY

Once-a-Week Rosuvastatin (2.5 to 20 mg) in Patients With a Previous Statin Intolerance

(2008) Janelle F. Ruisinger et al.   AMERICAN JOURNAL OF CARDIOLOGY